跳至主要内容
临床试验/NCT01080625
NCT01080625已完成不适用

Effect of Preventive Medicine on the Postreperfusion Syndrome

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
96
试验地点
1
主要终点
Occurrence of Postreperfusion Syndrome (PRS)

研究概览

简要总结

Postreperfusion syndrome (PRS) is a relatively common phenomenon in patients undergoing liver transplantation which is characterized by an acute drop in blood pressure immediately after the prefusion is restored to the transplanted liver. We hypothesized that PRS would be prevented when phenylephrine or epinephrine is administered immediately prior to reperfusion in liver transplantation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults scheduled to undergo liver transplantation

排除标准

  • pediatric liver transplantation

研究组 & 干预措施

phenylephrine

Experimental

100 mcg of phenylephrine is administered at the time of reperfusion

干预措施: phenylephrine (Drug)

epinephrine

Experimental

10 mcg of epinephrine is administered iv at the time of reperfusion

干预措施: epinephrine (Drug)

control

Placebo Comparator

10 ml of normal saline is administered at the time of reperfusion

干预措施: placebo control (Drug)

结局指标

主要结局

Occurrence of Postreperfusion Syndrome (PRS)

时间窗: immediately after reperfusion

the number of patients who showed PRS (hypotension defined as \< 30% of baseline mean arterial pressure \[MAP\] lasting over 1 min immediately after reperfusion of liver graft) was divided by the total number of patients enrolled for each group

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chul-Woo Jung

Assistant professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验

Effect of Epinephrine/ Phenylephrine for Preventing... | 临床试验